Antonio Esquivel Gaytan

Physician-Scientist (MD, MSc, PhDc).
Bridging Clinical Cardiology & Artificial Intelligence.

Building auditable, regulation-aware (MDR/GCP) AI tools for clinical workflows. Expert in heart failure, cardiorenal research, and translational medicine.

Clinical AI Heart Failure Privacy-First Python/FastAPI

Professional Log

Jun 2025 – Sep 2025

Clinical Research Investigator & AI Lead

Pangaea Oncology — Barcelona

Supervised AI-assisted visit management systems. Orchestrated human-in-the-loop governance for clinical reporting, ensuring MDR/GCP compliance and reducing hallucinations through prompt engineering and SOPs.

AI in Clinical Trials GCP Workflow

2024 – 2025

Co-founder (MVP)

QGuard-Med — Groningen

Finalist at "Break The Gap 2025". Developed a transparent, explainable AI scoring system for cardiovascular patient prioritization using FastAPI and Docker.

Prioritisation FastAPI

Nov 2018 – Present

PhD Researcher

UMCG — Netherlands

Experimental Cardiology. Investigating 5-oxoproline/OPLAH. Focused on high-throughput screening assays, cardiorenal interactions, and robust data analysis (Z′, S/B).

Biomarkers Translational

Credentials

Education

PhD Biomedical Sciences
UMCG / Univ. Groningen (2018 - Present)

MSc Nanotechnology
UCL, UK - Distinction (2016 - 2017)

MD (Physician)
UNAM, Mexico (2009 - 2016)

Competencies

LLM Workflows RAG Python (APIs) Docker/Git MDR / GCP Omics

Languages

Spanish (Native) · English (Full Prof.) · Dutch (B1-B2)

Selected Projects

Offline RAG Guidelines

Local guideline assistant (MVP). Zero PHI leakage, citation-backed.

Privacy-First

SOP Lab Assistant

Digitized SOPs with "bench run" mode and compliance logging.

Automation

QGuard-Med

Transparent prioritization system integrating clinical criteria & biomarkers.

Clinical AI

Publications

404-error “Disease not found”...

European Journal of Heart Failure (2024)

Co-authored work integrating omics to challenge conventional HF classification.

Glutathione deficiency and HF...

ESC Heart Failure (2025)

Systematic review on glutathione, oxidative stress, and heart failure.

A translation re-initiation variant in KLHL24...

British Journal of Dermatology (2022)

Co-authorship on genotype–phenotype work linking KLHL24 variants.

Elevated 5-Oxoproline Levels...

Redox Biology (Under Review)

Integrates clinical and experimental data to link 5-oxoproline and adverse outcomes.